Does the use of Pantavit LV lead to increased risk of fractures?
Nov 5, 2023
Does the use of Pantavit LV lead to increased risk of fractures?
Numerous studies conducted on adults have revealed that Pantavit LV may potentially amplify the likelihood of developing osteoporosisrelated fractures specifically affecting the hip wrist or spine It has been observed that the risk of fracture tends to escalate among patients who are administered high doses of the medication A high dose entails the consumption of multiple daily dosages over an extended period of time typically lasting a year or longer These findings highlight the significance of cautiousness and vigilant monitoring when it comes to the administration of Pantavit LV particularly in individuals who may be susceptible to osteoporosis or those who require a prolonged course of treatment By understanding and acknowledging these potential risks healthcare professionals can employ appropriate measures to mitigate the chances of fractures providing optimal care and safety to their patients